KEVIN G. COOPER
CARELLA BYRNE CECCHI BRODY & AGNELLO
- Address of record
- 5 BECKER FARM ROAD, ROSELAND, NJ 07068, 973-994-1700
- Phone
- (973) 994-1700
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
Chavez v. Plan Professionals ERISA Class Action
A proposed class action alleging violations of the Employee Retirement Income Security Act (ERISA) against Plan Professionals, LLC. The lawsuit apparently concerns the administration or management of employee benefit plans, potentially affecting plan participants and beneficiaries.
- Filed
- March 16, 2026
- Represents
- JOSE CHAVEZ, SARA FAZIO, PIERCE LANNUE
Eagle Pharma Securities Litigation Settlement
Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.
- Claim deadline
- October 16, 2026
- Represents
- NICHOLAS MILLER
Catalent Securities Settlement
Catalent, Inc. is facing a securities class action lawsuit brought by the City of Warwick Retirement System on behalf of investors. The settlement resolves claims related to publicly traded common stock and options that allegedly experienced price issues during the class period from August 30, 2021 through May 7, 2023.
- Claim deadline
- May 26, 2026
- Represents
- SEB INVESTMENT MANAGEMENT AB, PUBLIC EMPLOYEES RETIREMENT SYSTEM OF MISSISSIPPI
Kornit Digital Ltd. Securities Litigation Settlement
Kornit Digital Ltd. and its executives are accused of securities fraud in this class action lawsuit. The defendants have denied all claims and admit no wrongdoing, but have agreed to settle the case for $19.5 million to eliminate the burden and expense of continued litigation.
- Settlement fund
- $19.5M
- Claim deadline
- December 10, 2026
- Represents
- INSTITUTIONAL INVESTORS GROUP
Becton, Dickinson and Company Securities Litigation Settlement
Becton, Dickinson and Company and its former CEO Thomas E. Polen allegedly violated federal securities laws by misrepresenting the nature, extent, and revenue impact of undisclosed product issues, compliance violations, and FDA scrutiny regarding BD's Alaris infusion pump system during November 2019 to February 2020. The defendants have denied all wrongdoing while agreeing to settle for $85 million.
- Settlement fund
- $85M
- Claim deadline
- June 14, 2024
- Represents
- INDUSTRIENS PENSIONSFORSIKRING A/S
Aurora Cannabis Securities Litigation
Aurora Cannabis Inc. and executives Terry Booth and Allan Cleiren were accused of violating federal securities laws by making material misrepresentations about the company's business and prospects. The defendants deny all wrongdoing, and the parties agreed to settle the case for $8.05 million in cash without the court deciding in favor of either side.
- Settlement fund
- $8.1M
- Claim deadline
- Represents
- DOUG DAULTON, FRANCISCO QUINTANA, MATT GOLIS, DONALD S. PARISH, QUANG MA
Celgene Corporation Securities Litigation Settlement
Celgene Corporation and certain of its officers violated federal securities laws by making false and misleading statements regarding pharmaceutical drugs and drug candidates, including GED-0301, Otezla, and Ozanimod during the class period. The defendants' misconduct allegedly damaged investors who purchased Celgene common stock.
- Settlement fund
- $239M
- Claim deadline
- April 13, 2026
- Represents
- AMF PENSIONSFORSAKRING AB
Novo Nordisk Securities Litigation Settlement
Novo Nordisk and three individual executives allegedly violated federal securities laws by making false and misleading statements about the company's business and financial results. The defendants deny all allegations and maintain they have valid defenses. The settlement was approved for $100 million in July 2022.
- Settlement fund
- $100M
- Claim deadline
- Represents
- LEHIGH COUNTY EMPLOYEES' RETIREMENT SYSTEM
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.